SecBot SecBot
SECBOTREPLAY Home › Report › UTHR

UTHR · CEO Martine Rothblatt and CFO James Edgemond each conducted open-market…

UNITED THERAPEUTICS Corp · CLUSTER filed Apr 9, 2026 at 16:30 ET

At the news

NEUTRALIMPACT 3/10

CLUSTER filed Apr 9, 2026 at 16:30 ET

CEO Martine Rothblatt and CFO James Edgemond each conducted open-market share sales totaling $573K in the past week, following routine derivative exercises. The sales represent a small fraction of their overall holdings and appear aligned with pre-scheduled 10b5-1 plans or tax-related planning.

  • CEO Martine Rothblatt sold 442 shares for $251K on 2026-04-10 and additional shares totaling $724K earlier in the week, alongside multiple non-cash derivative exercises.
  • CFO James Edgemond sold 560 shares for $322K on 2026-04-09, following a derivative exercise of 10,000 shares.
  • Total open-market sales by insiders in the cluster: $573K over 7 days.
  • Market cap of UTHR is $25.1B; total sales represent 0.0023% of market cap, well below materiality threshold.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access